Given the absence of homozygous TP53 deletion, and because p53R172H has been shown to contribute to metastasis in other mouse models, we investigated whether p53R172H enhances HCC progression relative to p53 nullizygosity. Here, TP53 is linked to hepatocellular carcinoma.